MAKROLID-FORMULIERUNG MIT VERZÖGERTER WIRKSTOFFABGABE
摘要
Providing an oral formulation of a macrolide compound where the dissolution of the macrolide compound is under sustained release; and a sustained-release formulation containing a composition in solid solution, where the macrolide compound is present at an amorphous state in a solid base.